Does Virginia Medicaid cover Wegovy or Zepbound?
Last updated
Yes, narrowly: Virginia Medicaid covers GLP-1s for weight loss only at a BMI over 40 (37 with a risk factor).
If your plan says no: the lowest cash prices in Virginia

Lowest compounded semaglutide in Virginia on a monthly plan, not FDA-approved
$59/mo + $199/yr membership · about $29 less over a year than Sunlight, membership included · first order: membership free for the first 21 days, never charged if you cancel before

Next lowest per 30 days, supply stated: compounded semaglutide in Virginia
$78/mo · ≈ $84 per 30 days

Lowest compounded tirzepatide in Virginia on a monthly plan, not FDA-approved
$69/mo + $199/yr membership · about $389 less over a year than FlatRx, membership included · first order: membership free for the first 21 days, never charged if you cancel before

Next lowest per 30 days, supply stated: compounded tirzepatide in Virginia
$129/mo · ≈ $138 per 30 days
- F


Yes, but narrowly: Virginia Medicaid is one of the 13 programs KFF counted covering GLP-1s for obesity treatment as of January 2026 (KFF, Medicaid Coverage of and Spending on GLP-1s (January 2026), kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s, read Nov 17, 2026), and its own criteria, effective Oct 20, 2026, say: "BMI > 40 kg/m2 if no applicable risk factors; OR BMI > 37 kg/m2 with one or more of the following risk factors: dyslipidemia, hypertension, or type 2 diabetes; AND Member has tried and failed one of the non-GLP1 weight-loss medications" (Virginia DMAS service authorization form, Weight-Loss Management (effective October 20, 2026), virginiamedicaidpharmacyservices.com, read Nov 17, 2026). Utah, Massachusetts, and Rhode Island have ended theirs since, by their own notices, and Virginia is not among them. Every program must still cover some uses: in KFF's words, "coverage of GLP-1 drugs for the treatment of obesity remains optional for states, while coverage is required for drugs approved for the treatment of diabetes and, since March 2024 and December 2024, for the treatment of cardiovascular disease (Wegovy) and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound), respectively". Paying cash in Virginia, the lowest on a monthly plan at sellers whose own pages say they serve the state: compounded semaglutide from $59/mo + $199/yr membership at Collective (about $76 a month over a year) and compounded tirzepatide from $69/mo + $199/yr membership at Collective (about $86 a month over a year). Compounded medicines are not FDA-approved.
Virginia Medicaid and GLP-1s: common questions
Does Virginia Medicaid cover Wegovy?
For weight loss, Virginia Medicaid covers GLP-1s only at a BMI over 40 (37 with a risk factor), by the state's own criteria (Virginia DMAS service authorization form, Weight-Loss Management (effective October 20, 2026), virginiamedicaidpharmacyservices.com, read Nov 17, 2026). Every Medicaid program must cover Wegovy for the treatment of cardiovascular disease, KFF notes, with the state's own criteria. Wegovy not covered: the cash price at your dose
Does Virginia Medicaid cover Zepbound?
For weight loss, Virginia Medicaid covers GLP-1s only at a BMI over 40 (37 with a risk factor), by the state's own criteria (Virginia DMAS service authorization form, Weight-Loss Management (effective October 20, 2026), virginiamedicaidpharmacyservices.com, read Nov 17, 2026). Every Medicaid program must cover Zepbound for moderate to severe obstructive sleep apnea in adults with obesity, KFF notes, with the state's own criteria. Zepbound not covered: the cash price at your dose
Does Virginia Medicaid cover Ozempic or Mounjaro?
For type 2 diabetes, yes: in KFF's words, "coverage of GLP-1 drugs for the treatment of obesity remains optional for states, while coverage is required for drugs approved for the treatment of diabetes and, since March 2024 and December 2024, for the treatment of cardiovascular disease (Wegovy) and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound), respectively." Ozempic and Mounjaro are approved for type 2 diabetes. For weight loss alone, Virginia Medicaid covers GLP-1s only at a BMI over 40 (37 with a risk factor).
How much do Wegovy and Zepbound alternatives cost in Virginia without Medicaid?
Paying cash in Virginia, the lowest on a monthly plan at sellers whose own pages say they serve the state: compounded semaglutide from $59/mo + $199/yr membership at Collective (about $76 a month over a year) and compounded tirzepatide from $69/mo + $199/yr membership at Collective (about $86 a month over a year). Compounded medicines are not FDA-approved. Semaglutide: advertised as $59/mo + $199/yr membership at Collective, checked Nov 15, 2026 on collective.org. Tirzepatide: advertised as $69/mo + $199/yr membership at Collective, checked Nov 15, 2026 on collective.org. Liraglutide: advertised as $408.99/4 weeks at NuBloom, checked Nov 14, 2026 on mynubloom.com. Every compounded price in Virginia
Which states' Medicaid covers GLP-1s for weight loss?
10 programs, by KFF's January 2026 map and the states' own notices since: Delaware, Kansas, Michigan, Minnesota, Mississippi, Missouri, North Carolina, Tennessee, Virginia, and Wisconsin. Every state's Medicaid and GLP-1s
What Virginia Medicaid paid for
From Q2 2025 to Q1 2026, Virginia's Medicaid program reported 222,787 GLP-1 prescriptions to CMS, 43,483 of them for brands approved for weight management (Wegovy, Zepbound and Saxenda), which ranks 10 among the states on those brands. A paid prescription does not say what it was prescribed for. Every state's prescriptions
GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.